Patent Expiry
BCRX: RAPIVAB: recorded patent 8778997 expiry
May 7, 2027 · PERAMIVIR. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- May 7, 2027
- Company
- BIOCRYST PHARMACEUTICALS INC (BCRX)
- Drug
- PERAMIVIR
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
RAPIVAB: recorded patent 8778997 expiry
Orange Book application NDA206426, product 001, listed patent 8778997 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- PERAMIVIR